Brand Name(s): HWA 285
CAS nº: 55242-55-2
(proe PEN toe fi leen)
What is Propentofylline?
Propentofylline (a xanthine derivative) is a neuroprotective glial cell modulator.
This medicine has been shown in preclinical studies to address some of the common pathological processes of Alzheimer's disease (PDD) and/or vascular dementia (MID), including glial cell activation and increased production of cytokines, free radicals, and glutamate.
Latest News
New Computer Analysis Detects Early Alzheimer's Disease
A new computer-based technique may help find early cell damage in people who have Alzheimer's...
[more]Behavioral Manifestations of Alzheimer's Disease
Alzheimer’s Dementia has a combination of cognitive and behavioral manifestations.
[more]Aventis Pharma Discontinues Development of Propentofylline
Aventis Pharma (Frankfurt, Germany) the pharmaceutical company of Aventis S.A., has announced that...
[more]Propentofylline for Alzheimer's, Dementia
Patients with Alzheimer's disease and vascular dementia responded well to propentofylline, a drug...
[more]Two New Therapies 'Buy More Quality Time' for Alzheimer's Patients
Two new drugs, one already approved by the FDA, are showing promise for people suffering from...
[more]